| Cat. No. |
Product Name |
Information |
| PC-49785 |
ISM042-2-048
CDK20 inhibitor
|
ISM042-2-048 is a potent, selective inhibitor of cyclin-dependent kinase 20 (CDK20, cell cycle-related kinase/CCRK) with IC50 of 33.4 nM (CDK20/CycT1), Kd value of 566 nM. |
| PC-49575 |
PF-07220060
CDK4 inhibitor
|
PF-07220060 (CDK4/6-IN-6) is a potent and selective, orally active CDK4 inhibitor with Ki of 0.6 nM (CDK4/Cyclin D1), significant sparing of CDK6 (Ki=13.9 nM CDK6/Cyclin D3). |
| PC-49485 |
KB-0742 dihydrochloride
CDK9 inhibitor
|
KB-0742 (KB0742) is a potent, orally bioavailable, selective CDK9 inhibitor with IC50 of 6 nM (CDK9/cyclin T1 inhibition). |
| PC-49444 |
MK256
CDK8/19 inhibitor
|
MK256 (MK-256) is a potent, selective CDK8 inhibitor with IC50 of 2.5 nM and 3.3 nM against CDK8/cyclin C and CDK19/cyclin C, respectively. |
| PC-49260 |
ZSQ836
CDK12/13 inhibitor
|
ZSQ836 (ZSQ 836) is a potent, selective and orally bioavailable CDK12/CDK13 covalent inhibitor with IC50 of 32 nM (CDK12), covalently interacts with Cys1039 of CDK12. |
| PC-49204 |
SNX631
CDK8/19 inhibitor
|
SNX631 (SNX-631) is a potent, selective inhibitor of CDK8/19 Mediator kinase with IC50 of 10.3 nM in the NF κB-dependent cell-based assays. |
| PC-49131 |
Culmerciclib
CDK4/6 inhibitor
|
TQB3616 (Culmerciclib) is a potent, selective inhibitor of CDK4/6 with IC50 of 0.35 nM and 0.49 nM for CDK4/D1CDK6/D1 respectively, shows remarkable inhibitory effect on hormone receptor-positive breast cancer cells. |
| PC-49130 |
Crozbaciclib
CDK4/6 inhibitor
|
Crozbaciclib is a highly potent, selective, blood-brain barrier (BBB) permeable CDK4/6 inhibitor with IC50 values of 3 nM and 1 nM against CDK4/cyclin D1 and CDK6/cyclin D3, respectively. |
| PC-49076 |
CDK inhibitor 24
CDK inhibitor
|
CDK inhibitor 24 is a potent inhibitor of cyclin-dependent kinases (CDKs) with IC50 of 4/20/64 nM for CDK2/9/12, respectively. |
| PC-47100 |
YPN-005
CDK7 inhibitor
|
YPN-005 (YPN005) is a highly potent, selective inhibitor of cyclin-dependent kinase 7 (CDK7) with IC50 of 31 nM, with low inhibition for CDK2 and CDK5. |
| PC-38758 |
Zotiraciclib
CDK/JAK2/FLT3 inhibitor
|
Zotiraciclib (TG02, SB1317) is a potent multi-kinase inhibitor of cyclin dependent kinases (CDKs), JAK2, and FLT3 with IC50of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, respectively. |
| PC-38340 |
Avotaciclib
CDK1 inhibitor
|
Avotaciclib (BEY1107) is a potent, selective CDK1 (Cyclin-Dependent Kinase 1) inhibitor, inhibits self-replication of cancer stem cells and is a candidate for pancreatic cancer treatment. |
